The rate of sexually transmitted infections (STIs) is on the rise in the U.S. and significant changes to treatment regimens have emerged with recent guideline updates. Pharmacists have an important role in mitigating the spread with appropriate screening and monitoring strategies. Connect your learning to practice with these real-world cases and be ready to impact the health and well-being of your patients at risk for STIs.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Apply current sexually transmitted infection guidelines to specific patient cases involving gonorrhea and chlamydia
2. Utilize specific patient medical history, medications, and laboratory results to optimize sexually transmitted infection management
3. Recommend an HPV vaccination schedule based on patient demographics and the CDC immunization schedule
4. Evaluate the risk of an unknown penicillin allergy for a patient prescribed ceftriaxone 

Timothy Gauthier, Pharm.D., BCPS, BCIDP
Pharmacist
Baptist Health South Florida

Dr. Gauthier reports:

• Consultant and/or paid collaborations with Spectrum Mobile Health, Pattern Biosciences, GoodRx, DoseMeRx Pty, Antimicrobial Therapy Inc, VinPin, Pharmageddon card game
• Owner of Charlie Rose, LLC (www.LearnAntibiotics.com, www.IDstewardship.com)
• The views and opinions in this presentation are that of the presenter and do not necessarily represent the policy or position of any former, current, or potential future employer
• All of the relevant financial relationships listed have been mitigated.  

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: November 1, 2022
Planned Expiration Date: November 1, 2025

Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.